Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

Lancet Infectious Diseases

Volumn 4, Issue 6, 2004, Pages 349-357

  Mennink Kersten, Monique A S H ^a   Donnelly, J Peter ^a   Verweij, Paul E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FUNGAL DNA; GALACTOMANNAN; GLUCOSE; ITRACONAZOLE; MONOCLONAL ANTIBODY; OXYGEN;

ANTIGEN DETECTION; ASPERGILLOSIS; ASPERGILLUS NIGER; BLEEDING; BLOOD; BLOOD VESSEL; CHEMICAL STRUCTURE; CIRCULATION; COMPUTER ASSISTED TOMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGUS GROWTH; FUNGUS HYPHAE; HEALTH PROGRAM; HOST PARASITE INTERACTION; HUMAN; LUNG PARENCHYMA; NORMAL VALUE; PENICILLIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN SECRETION; RABBIT; REVIEW; RISK FACTOR; UNITED STATES;

ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MANNANS; REAGENT KITS, DIAGNOSTIC;

EID: 2542436813     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(04)01045-X     Document Type: Review

References (47)

1. Fukuda T, Boeckh M, Carter RA, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood. 102:2003;827-833
2. Martino R, Subira M. Invasive fungal infections in hematology: new trends. Ann Hematol. 81:2002;233-243
3. Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant. 22:2003;258-266
4. Perfect JR, Marr KA, Walsh TJ, et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis. 36:2003;1122-1131
5. Ruhnke M, Maschmeyer G. Management of mycoses in patients with hematologic disease and cancer - review of the literature. Eur J Med Res. 7:2002;227-235
6. Reiss E, Obayashi T, Orle K, Yoshida M, Zancope-Oliveira RM. Non-culture based diagnostic tests for mycotic infections. Med Mycol. 38:(suppl 1):2000;147-159
7. Rohrlich P, Sarfati J, Mariani P, et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J. 15:1996;232-237
8. US Food and Drug Administration; http://www.fda.gov/bbs/topics/NEWS/2003/ NEW/00907.html; accessed January 2004.
9. Sulahian A, Taboure t M, Ribaud P, et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis. 15:1996;139-145
10. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood. 97:2001;1604-1610
11. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer. 91:2001;311-318
12. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol. 20:2002;1898-1906
13. Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis. 186:2002;1297-1306
14. Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der Schee C, Hoogsteden HC, De Marie S. Galactomannan detection in computerized tomography-based bronchoalveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol. 121:2003;448-457
15. Pinel C, Fricker-Hidalgo H, Lebeau B, et al. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol. 41:2003;2184-2186
16. Verweij PE, Donnelly JP, De Pauw BE, Meis JFGM. Prospects for the early diagnosis of invasive aspergillois in the immunocompromised host. Rev Med Microbiol. 7:1996;105-113
17. Severens JL, Donnelly JP, Meis JF, De Vries Robbe PF, De Pauw BE, Verweij PE. Two strategies for managing invasive aspergillosis: a decision analysis. Clin Infect Dis. 25:1997;1148-1154
18. Sarfati J, Boucias DG, Latge JP. Antigens of Aspergillus fumigatus produced in vivo. J Med Vet Mycol. 33:1995;9-14
19. Latge JP, Kobayashi H, Debeaupuis JP, et al. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun. 62:1994;5424-5433
20. Stynen D, Sarfati J, Goris A, et al. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun. 60:1992;2237-2245
21. Deacon JW. Modern Mycology. 1997;Blackwell Science, Oxford
22. Burgstaller W. Transport of small lons and molecules through the plasma membrane of filamentous fungi. Crit Rev Microbiol. 23:1997;1-46
23. Kauffman HF, de Vries K. Antibodies against Aspergillus fumigatus. I. Standardization of the antigenic composition. Int Arch Allergy Appl Immunol. 62:1980;252-264
24. Kubicek CP, Witteveen CFB, Visser J. Regulation of organic acid production by aspergilli. Powell KA, Renwick A, Peberdy JF. The genus Aspergillus. 1994;135-145 Plenum, New York
25. Fontaine T, Simenel C, Dubreucq G, et al. Molecular organization of the alkali-insoluble fraction of Aspergillus fumigatus cell wall. J Biol Chem. 275:2000;27594-27607
26. Wallis GL, Hemming FW, Peberdy JF. An extracellular beta- galactofuranosidase from Aspergillus niger and its use as a tool for glycoconjugate analysis. Biochim Biophys Acta. 1525:2001;19-28
27. Wallis GL, Swift RJ, Atterbury R, et al. The effect of pH on glucoamylase production, glycosylation and chemostat evolution of Aspergillus niger. Biochim Biophys Acta. 1527:2001;112-122
28. Park YI, Buszko ML, Gander JE. Utilization of phosphocholine from extracellular complex polysaccharide as a source of cytoplasmic choline derivatives in Penicillium fellutanum. J Bacteriol. 179:1997;1186-1192
29. Leitao EA, Bittencourt VC, Haido RM, et al. Beta-galactofuranose- containing O-linked oligosaccharides present in the cell wall peptidogalactomannan of Aspergillus fumigatus contain immunodominant epitopes. Glycobiology. 13:2003;681R-692R
30. Bonetti SJ, Groves SE, Black B, Gander JE. Heat shock treatment releases penicillium phosphoglycopeptide. Phytochemistry. 47:1998;567-575
31. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 12:1999;310-350
32. Berenguer J, Allende MC, Lee JW, et al. Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone- induced immunosuppression. Am J Respir Crit Care Med. 152:1995;1079-1086
33. Verweij PE, Weemaes CM, Curfs JH, Bretagne S, Meis JF. Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol. 38:2000;3900-3901
34. Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore). 49:1970;147-173
35. Franquet T, Muller NL, Gimenez A, Guembe P, de La Torre J, Bague S. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics. 21:2001;825-837
36. Logan PM, Muller NL. High-resolution computed tomography and pathologic findings in pulmonary aspergillosis: a pictorial essay. Can Assoc Radiol J. 47:1996;444-452
37. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol. 15:1997;139-147
38. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 347:2002;408-415
39. Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol. 33:2003;453-460
40. Bennett JE, Friedman MM, Dupont B. Receptor-mediated clearance of Aspergillus galactomannan. J Infect Dis. 155:1987;1005-1010
41. Mennink-Kersten MA, Klont RR, Warris A, Op den Camp HJ, Verweij PE. Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection. Lancet. 363:2004;325-327
42. Sulahian A, Touratier S, Ribaud P. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med. 349:2003;2366-2367
43. Ansorg R, van den Boom R, Rath PM. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses. 40:1997;353-357
44. Francis P, Lee JW, Hoffman A, et al. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. J Infect Dis. 169:1994;356-368
45. Becker MJ, de Marie S, Fens MH, Verbrugh HA, Bakker-Woudenberg IA. Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis. J Antimicrob Chemother. 52:2003;428-434
46. Petraitiene R, Petraitis V, Groll AH, et al. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia. Antimicrob Agents Chemother. 45:2001;857-869
47. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 34:2002;7-14